Company: XAIR
Filing Date: 2025-11-21
Form Type: S-1
Source: 0001493152-25-024614
Chunk: 25

Company: Beyond Air, Inc.
Filing Date: 2025-11-21
Form: S-1
Chunk 25
---
ement offer, the Company issued new common stock warrants to purchase up to 719,562 shares of common stock for a purchase price of $0.125 per share of common stock underlying the new warrant. The new warrants have an exercise price of $2.21 per share and are immediately exercisable, with a term of five years from the issuance date.

On November 1, 2024, in connection with a secured loan to related parties including our Chief Executive Officer and a director, we issued five-year warrants to purchase up to 757,975 shares of common stock at an exercise price of $7.586 per share. On November 4, 2025, we entered into a Waiver Agreement (the “Waiver”), pursuant to which the lenders consented to the Company’s issuance of the Note in exchange for reducing the exercise price of their existing warrants to $1.95 per share.

On September 30, 2024 we issued aggregate of (i) 1,250,000 shares of common stock at a purchase price of $10.086 per share, (ii) pre-funded warrants to purchase up to 792,445 shares of common stock at a purchase price of $10.084 per pre-funded warrant and (iii) warrants to purchase up to 2,042,442 shares of common stock, for aggregate gross proceeds of $20,600,000. The pre-funded warrants have an exercise price of $0.002 per share, and the common warrants have an exercise price of $7.586 per share.

These above securities were issued in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act.

| Item 
 16.  | Exhibits                          
 and Financial Statement Schedules |

Exhibits

See the Exhibit Index immediately preceding the signature page hereto for a list of exhibits filed as part of this registration statement, which Exhibit Index is incorporated herein by reference.

Financial Statement Schedules

All financial statement schedules are omitted because the information called for is not required or is shown either in the financial statements or in the accompanying notes.

| II-2 |

| Item 
 17.  | Undertakings |

| (a) | The                                       
 undersigned registrant hereby undertakes: |

| (1) | To                                                                                                                          
 file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |

| (i)  | to                                                                                                                                    
 include any prospectus required by Section